Sales rise 36.84% to Rs 645.24 crore
Net profit of Epigral rose 111.15% to Rs 103.63 crore in the quarter ended December 2024 as against Rs 49.08 crore during the previous quarter ended December 2023. Sales rose 36.84% to Rs 645.24 crore in the quarter ended December 2024 as against Rs 471.52 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales645.24471.52 37 OPM %28.2925.99 -PBDT186.53104.81 78 PBT153.6273.93 108 NP103.6349.08 111Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content